Papers from every journal, all in one place. Create custom feeds.
LAAC raises ischemic stroke risk while halving nonprocedural bleeding versus OAC; challenges composite-endpoint reliance and extends calls for individual-outcome RCTs.

May support 6-mm ILD PVI with TactiFlex in paroxysmal AF; leaves open durability and outcome confirmation.

May warrant caution with pulsed field ablation for AF; leaves open confirmation in randomized trials.
Cardiologist, Beth Israel Deaconess Medical Center
The 30-day rate of stroke/TIA was significantly higher for PFA cases (10 events; 0.47%) compared with RFA (2 events; 0.10%) in both unweighted and propensity score–weighted analyses (weighted risk difference, 0.36% [95% CI, 0.03%–0.70%]; P=0.03).
Supports post-MI dietary counseling; leaves open whether interventions improve survival in trials.

Internal Medicine Specialist, Private Clinic, Ankara
A 33% reduction in mortality is not a marginal gain; it is a fundamental shift in trajectory. Most importantly, this research dispels any sense of fatalism following a cardiac event. Even if your diet was poor before your heart attack, improving it afterward is independently associated with better survival.
Provides hypothesis-generating mechanistic insights into right ventricular failure in PH-HFpEF;.

interventional cardiologist, VitalSolution
This study may signify a paradigm shift in our understanding of heart failure with preserved ejection fraction. Patients who concurrently develop pulmonary vascular remodeling and right ventricular dysfunction may represent a fundamentally distinct and significantly elevated risk group compared to those with standard uncomplicated heart failure with preserved ejection fraction. The main clinical message from this study is that heart failure with preserved ejection fraction should be viewed as a disease of the entire cardiopulmonary system, rather than simply a disease isolated to the left ventricle.
Endocardial PFA yields durable transmural mitral isthmus block in only ~52% of cases; leaves open the role of adjunctive strategies in AF ablation.

Planned RCT tests wearables for lifestyle adherence targeting cfPWV and VO2max; leaves open clinical efficacy in CVD prevention.

Supports ICD consideration in selected HCM patients; leaves optimal risk stratification open for prospective trials.

Tirzepatide-associated lower cerebrovascular risk in AF with T2D; hypothesis-generating, needs randomized confirmation before practice change.

Imaging phenotypes may refine CVD risk assessment beyond BMI; leaves open whether they improve outcomes or warrant routine use.